
BlossomHill Therapeutics, Inc.
BLSMHealthcare|Biotechnology|US
$13.50
+1.15 (+9.31%)
DCF Value
$3.85
Tangible Book / Share
$3.02
Cash / Share
$3.51
Ownership Breakdown
77.7%
Float
29.1M
Shares Outstanding
22.6M
Float Shares
Major Holders (17)
Combined: 93.7%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Chen Bihua | Individual | 11.80% | 3,615,362 | Aug 13, 2026 | 13D/G |
| Cormorant Asset Management, LP | IA, PN | 11.79% | 3,614,034 | Aug 13, 2026 | 13D/G |
| Orbimed Advisors LLC | Investment adviser | 8.90% | 2,714,279 | Aug 18, 2026 | 13D/G |
| OrbiMed Capital GP VIII LLC | Other | 8.90% | 2,714,279 | Aug 18, 2026 | 13D/G |
| Perceptive Advisors LLC | Investment adviser | 5.90% | 1,808,533 | Aug 14, 2026 | 13D/G |
| Joseph Edelman | Individual | 5.90% | 1,808,533 | Aug 14, 2026 | 13D/G |
| Perceptive Life Sciences Master Fund, Ltd. | Corporation | 5.90% | 1,808,533 | Aug 14, 2026 | 13D/G |
| Vivo Innovation Fund II Holdings, L.P. | Partnership | 5.50% | 1,681,240 | Aug 17, 2026 | 13D/G |
| Vivo Innovation II, LLC | Other | 5.50% | 1,681,240 | Aug 17, 2026 | 13D/G |
| Cormorant Private Healthcare Fund III, LP | Partnership | 4.01% | 1,228,315 | Aug 13, 2026 | 13D/G |
| Cormorant Private Healthcare GP III, LLC | Other | 4.01% | 1,228,315 | Aug 13, 2026 | 13D/G |
| Cormorant Private Healthcare Fund V, LP | Partnership | 3.43% | 1,052,460 | Aug 13, 2026 | 13D/G |
| Cormorant Private Healthcare GP V, LLC | Other | 3.43% | 1,052,460 | Aug 13, 2026 | 13D/G |
| Cormorant Global Healthcare Master Fund, LP | Partnership | 3.13% | 959,090 | Aug 13, 2026 | 13D/G |
| Cormorant Global Healthcare GP, LLC | Other | 3.13% | 959,090 | Aug 13, 2026 | 13D/G |
| Cormorant Private Healthcare GP VI, LLC | Other | 1.22% | 374,169 | Aug 13, 2026 | 13D/G |
| Cormorant Private Healthcare Fund VI, LP | Partnership | 1.22% | 374,169 | Aug 13, 2026 | 13D/G |
Insider Trades (68)
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| GORDON CARL L | director | Aug 10, 2026 | BUY | 625,000 | $16.00 | $10.0M | Form 4 |
| GORDON CARL L | director | Aug 10, 2026 | CONVERSION | 1,049,283 | — | — | Form 4 |
| GORDON CARL L | director | Aug 10, 2026 | CONVERSION | 1,039,996 | — | — | Form 4 |
| GORDON CARL L | director | Aug 10, 2026 | CONVERSION | 1,049,283 | — | — | Form 4 |
| GORDON CARL L | director | Aug 10, 2026 | CONVERSION | 1,039,996 | — | — | Form 4 |
| ORBIMED ADVISORS LLC | director | Aug 10, 2026 | BUY | 625,000 | $16.00 | $10.0M | Form 4 |
| ORBIMED ADVISORS LLC | director | Aug 10, 2026 | CONVERSION | 1,049,283 | — | — | Form 4 |
| ORBIMED ADVISORS LLC | director | Aug 10, 2026 | CONVERSION | 1,039,996 | — | — | Form 4 |
| ORBIMED ADVISORS LLC | director | Aug 10, 2026 | CONVERSION | 1,049,283 | — | — | Form 4 |
| ORBIMED ADVISORS LLC | director | Aug 10, 2026 | CONVERSION | 1,039,996 | — | — | Form 4 |
| Schmid John P. | director | Aug 10, 2026 | BUY | 6,000 | $16.00 | $96.0K | Form 4 |
| GORDON CARL L | director | Aug 6, 2026 | AWARD | 23,904 | $16.00 | $382.5K | Form 4 |
| Chen Bihua | director, 10 percent owner: | Aug 10, 2026 | BUY | 312,500 | $16.00 | $5.0M | Form 4 |
| Chen Bihua | director, 10 percent owner: | Aug 10, 2026 | CONVERSION | 1,701,541 | — | — | Form 4 |
| Chen Bihua | director, 10 percent owner: | Aug 10, 2026 | CONVERSION | 1,599,993 | — | — | Form 4 |
| Chen Bihua | director, 10 percent owner: | Aug 6, 2026 | AWARD | 23,904 | $16.00 | $382.5K | Form 4 |
| Chen Bihua | director, 10 percent owner: | Aug 10, 2026 | CONVERSION | 1,599,993 | — | — | Form 4 |
| Chen Bihua | director, 10 percent owner: | Aug 10, 2026 | CONVERSION | 1,701,541 | — | — | Form 4 |
| Agrawal Sundeep | director | Aug 10, 2026 | CONVERSION | 578,524 | — | — | Form 4 |
| Agrawal Sundeep | director | Aug 6, 2026 | AWARD | 23,904 | $16.00 | $382.5K | Form 4 |
| Agrawal Sundeep | director | Aug 10, 2026 | CONVERSION | 578,524 | — | — | Form 4 |
| Keyes Jason A | Chief Financial Officer | Aug 6, 2026 | AWARD | 56,746 | $16.00 | $907.9K | Form 4 |
| Keyes Jason A | Chief Financial Officer | Aug 10, 2026 | BUY | 700 | $16.00 | $11.2K | Form 4 |
| Liptak Vincent Paul | General Counsel | Aug 10, 2026 | BUY | 2,200 | $16.00 | $35.2K | Form 4 |
| Liptak Vincent Paul | General Counsel | Aug 7, 2026 | BUY | 2,500 | $15.80 | $39.5K | Form 4 |
| Liptak Vincent Paul | General Counsel | Aug 6, 2026 | AWARD | 46,561 | $16.00 | $745.0K | Form 4 |
| Liptak Vincent Paul | General Counsel | Aug 10, 2026 | CONVERSION | 22,687 | — | — | Form 4 |
| Liptak Vincent Paul | General Counsel | Aug 10, 2026 | CONVERSION | 22,687 | — | — | Form 4 |
| Oxnard Geoffrey Raymond | Chief Medical Officer | Aug 6, 2026 | AWARD | 61,783 | $16.00 | $988.5K | Form 4 |
| Li Yishan | director, 10 percent owner, officer: Executive Chairman | Aug 10, 2026 | CONVERSION | 113,435 | — | — | Form 4 |
| Li Yishan | director, 10 percent owner, officer: Executive Chairman | Aug 10, 2026 | CONVERSION | 1,600,682 | — | — | Form 4 |
| Li Yishan | director, 10 percent owner, officer: Executive Chairman | Aug 10, 2026 | CONVERSION | 124,779 | — | — | Form 4 |
| Li Yishan | director, 10 percent owner, officer: Executive Chairman | Aug 6, 2026 | AWARD | 112,701 | $16.00 | $1.8M | Form 4 |
| Li Yishan | director, 10 percent owner, officer: Executive Chairman | Aug 10, 2026 | CONVERSION | 1,600,682 | — | — | Form 4 |
| Li Yishan | director, 10 percent owner, officer: Executive Chairman | Aug 10, 2026 | CONVERSION | 113,435 | — | — | Form 4 |
| Li Yishan | director, 10 percent owner, officer: Executive Chairman | Aug 10, 2026 | CONVERSION | 124,779 | — | — | Form 4 |
| Cui Jingrong Jean | director, 10 percent owner, officer: President and CEO | Aug 10, 2026 | CONVERSION | 113,435 | — | — | Form 4 |
| Cui Jingrong Jean | director, 10 percent owner, officer: President and CEO | Aug 10, 2026 | CONVERSION | 1,600,682 | — | — | Form 4 |
| Cui Jingrong Jean | director, 10 percent owner, officer: President and CEO | Aug 6, 2026 | AWARD | 676,205 | $16.00 | $10.8M | Form 4 |
| Cui Jingrong Jean | director, 10 percent owner, officer: President and CEO | Aug 10, 2026 | CONVERSION | 124,779 | — | — | Form 4 |
| Cui Jingrong Jean | director, 10 percent owner, officer: President and CEO | Aug 10, 2026 | CONVERSION | 1,600,682 | — | — | Form 4 |
| Cui Jingrong Jean | director, 10 percent owner, officer: President and CEO | Aug 10, 2026 | CONVERSION | 113,435 | — | — | Form 4 |
| Cui Jingrong Jean | director, 10 percent owner, officer: President and CEO | Aug 10, 2026 | CONVERSION | 124,779 | — | — | Form 4 |
| ORBIMED ADVISORS LLC | director | Aug 6, 2026 | OTHER | 1,039,996 | — | — | Form 4 |
| ORBIMED ADVISORS LLC | director | Aug 6, 2026 | OTHER | 1,049,283 | — | — | Form 4 |
| Schmid John P. | director | Aug 6, 2026 | OTHER | 67,620 | $13.59 | $919.0K | Form 4 |
| GUJRATHI SHEILA | director | Aug 6, 2026 | OTHER | 0 | — | — | Form 4 |
| Agrawal Sundeep | director | Aug 6, 2026 | OTHER | 10,671 | $6.28 | $67.0K | Form 4 |
| Agrawal Sundeep | director | Aug 6, 2026 | OTHER | 578,524 | — | — | Form 4 |
| GORDON CARL L | director | Aug 6, 2026 | OTHER | 1,039,996 | — | — | Form 4 |
| GORDON CARL L | director | Aug 6, 2026 | OTHER | 1,049,283 | — | — | Form 4 |
| Chen Bihua | director, 10 percent owner: | Aug 6, 2026 | OTHER | 1,701,541 | — | — | Form 4 |
| Chen Bihua | director, 10 percent owner: | Aug 6, 2026 | OTHER | 1,599,993 | — | — | Form 4 |
| Liptak Vincent Paul | General Counsel | Aug 6, 2026 | OTHER | 0 | — | — | Form 4 |
| Liptak Vincent Paul | General Counsel | Aug 6, 2026 | OTHER | 22,687 | — | — | Form 4 |
| Oxnard Geoffrey Raymond | Chief Medical Officer | Aug 6, 2026 | OTHER | 0 | — | — | Form 4 |
| Oxnard Geoffrey Raymond | Chief Medical Officer | Aug 6, 2026 | OTHER | 152,373 | $5.63 | $857.9K | Form 4 |
| Oxnard Geoffrey Raymond | Chief Medical Officer | Aug 6, 2026 | OTHER | 34,031 | $6.28 | $213.7K | Form 4 |
| Keyes Jason A | Chief Financial Officer | Aug 6, 2026 | OTHER | 175,417 | $6.28 | $1.1M | Form 4 |
| Li Yishan | director, 10 percent owner, officer: Executive Chairman | Aug 6, 2026 | OTHER | 0 | — | — | Form 4 |
| Li Yishan | director, 10 percent owner, officer: Executive Chairman | Aug 6, 2026 | OTHER | 1,600,682 | — | — | Form 4 |
| Li Yishan | director, 10 percent owner, officer: Executive Chairman | Aug 6, 2026 | OTHER | 124,779 | — | — | Form 4 |
| Li Yishan | director, 10 percent owner, officer: Executive Chairman | Aug 6, 2026 | OTHER | 113,435 | — | — | Form 4 |
| Cui Jingrong Jean | director, 10 percent owner, officer: President and CEO | Aug 6, 2026 | OTHER | 0 | — | — | Form 4 |
| Cui Jingrong Jean | director, 10 percent owner, officer: President and CEO | Aug 6, 2026 | OTHER | 1,600,682 | — | — | Form 4 |
| Cui Jingrong Jean | director, 10 percent owner, officer: President and CEO | Aug 6, 2026 | OTHER | 124,779 | — | — | Form 4 |
| Cui Jingrong Jean | director, 10 percent owner, officer: President and CEO | Aug 6, 2026 | OTHER | 113,435 | — | — | Form 4 |
| Anderson John David | 10 percent owner | Aug 12, 2010 | DISPOSED | 0 | — | — | Form 4 |